In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts
about
ZNF9 activation of IRES-mediated translation of the human ODC mRNA is decreased in myotonic dystrophy type 2Muscleblind proteins regulate alternative splicingFailure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophyRNA-dependent integrin alpha3 protein localization regulated by the Muscleblind-like protein MLP1Comparative genomics and molecular dynamics of DNA repeats in eukaryotesElevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophyDefining early steps in mRNA transport: mutant mRNA in myotonic dystrophy type I is blocked at entry into SC-35 domains.HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence.There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALSThe importance of CELF control: molecular and biological roles of the CUG-BP, Elav-like family of RNA-binding proteinsRAN translation and frameshifting as translational challenges at simple repeats of human neurodegenerative disordersMechanisms of RNA-induced toxicity in CAG repeat disordersThe unstable repeats--three evolving faces of neurological diseaseDeregulated microRNAs in myotonic dystrophy type 2Identification of hepta-histidine as a candidate drug for Huntington's disease by in silico-in vitro- in vivo-integrated screens of chemical librariesStudying a Drug-like, RNA-Focused Small Molecule Library Identifies Compounds That Inhibit RNA Toxicity in Myotonic DystrophyDisease Phenotypes in a Mouse Model of RNA Toxicity Are Independent of Protein Kinase Cα and Protein Kinase CβEvaluating the effects of CELF1 deficiency in a mouse model of RNA toxicityDevelopment of an AP-FRET based analysis for characterizing RNA-protein interactions in myotonic dystrophy (DM1)PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1.Mechanistic determinants of MBNL activityRepression of nuclear CELF activity can rescue CELF-regulated alternative splicing defects in skeletal muscle models of myotonic dystrophyAutoregulation of MBNL1 function by exon 1 exclusion from MBNL1 transcript.Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome.MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicing.Myoblasts generated by lentiviral mediated MyoD transduction of myotonic dystrophy type 1 (DM1) fibroblasts can be used for assays of therapeutic molecules.Rationally designed small molecules targeting the RNA that causes myotonic dystrophy type 1 are potently bioactive.RNA-binding protein Muscleblind-like 3 (MBNL3) disrupts myocyte enhancer factor 2 (Mef2) {beta}-exon splicing.Dystrophia myotonia: why focus on foci?Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus.RNA structure of trinucleotide repeats associated with human neurological diseases.Characterization of MRP RNA-protein interactions within the perinucleolar compartment.Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of Muscleblind-like-1 isoformsZebrafish deficient for Muscleblind-like 2 exhibit features of myotonic dystrophy.High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines.The FMR1 gene and fragile X-associated tremor/ataxia syndrome.Microsatellite repeat instability and neurological disease.Overexpression of CUGBP1 in skeletal muscle from adult classic myotonic dystrophy type 1 but not from myotonic dystrophy type 2.Autoregulated splicing of muscleblind-like 1 (MBNL1) Pre-mRNA.Structures of trinucleotide repeats in human transcripts and their functional implications.
P2860
Q21142651-56AB51D5-A336-4E1B-B567-BCFFEECA7C4DQ24299521-1478AD11-E06F-494A-B8B1-13B42E465D88Q24337657-478E2E0F-F338-4878-BCE4-9DC82078D700Q24647775-D5C33C12-1DA9-4E9A-A62E-8F90C63A8B86Q24650948-F3F8C6CA-D16F-43F1-9A62-B52B39F4E07FQ24670706-B3179371-1311-4930-95D7-64A646DA215BQ24682706-5E045DB6-B118-410A-9B7E-C2378104ECDDQ24812815-8955242C-54ED-4703-B2E6-8AB3A946ADDEQ26750577-B1B77739-DB07-4283-9F79-2F0700533476Q26823119-79032622-2626-421A-9EF2-C90B6C538008Q26823908-859A1692-9AC7-4D37-88F9-B9C70ADCA3B4Q26860030-17912234-DE81-4E62-A8F4-42B3984880EAQ27025923-E2C911EA-2F41-4155-9932-C0F9234B4717Q28727681-4F255AC4-305E-42C2-B2A6-D590C419AA87Q28829351-5A2433FB-BB82-46F2-B62D-08CAD2ADDCADQ28830592-4329FDB0-794D-4A1C-B954-93FB713AACBBQ30275866-8E1B327A-39F1-4467-B29D-455486A3F482Q30408570-CCD7696B-E0FC-454A-ABE0-EB9F9465CB8BQ30413238-794D6233-1829-4081-BB8C-8F44FA28A125Q30492100-B38A00D3-6501-4346-ABEB-81AD225FDDEAQ30830825-508B8776-F114-4FB4-942B-3CF187F47C15Q31053307-801E171F-F1E0-4FFE-8ECC-3772378063D1Q33557647-5C635B0B-6A1E-46FB-AF51-138BE0937F1FQ33649463-0F9AD664-8A6B-4222-848D-F2F3EC7E1F03Q33783196-8579E17D-BCB8-4E32-A786-445BD5307DCBQ34073069-A5941226-5323-4472-975E-0254F0FE6223Q34158462-F99B078B-A778-4BE7-83A7-4A856F509FECQ34231994-5BC5BE01-D8AC-4AAD-961F-570F96C005D0Q34326165-E9451A34-1F8D-472F-93CB-231414C584A9Q34499428-1B17941A-A7E7-48C1-B36E-3E64AA02B8C0Q34542108-B11BFF77-3312-43C6-81F2-9B6D3C3CE83BQ34675264-52453460-DD81-4B67-B048-AA436088C49EQ34963754-AA30FCBE-AB86-439C-A7B9-CC73E5C0A7AAQ34990941-0F75D8FA-34E5-4085-90C5-30AAD550359DQ35030106-09C36005-11D9-4A6D-B83B-EF313BF9B107Q35061671-D639728F-71ED-4049-983F-9510A184E5FFQ35064141-47CFFAAF-C13E-4CEA-9F0A-D4D635525BC2Q35078193-12B96488-58B9-4F3E-A031-B0405CCC5F9BQ35310396-889A1A34-5422-44B9-9B65-ABA29BE0A8D0Q35538754-86AE4E8F-6A60-471F-B9AA-43AB421AAEFA
P2860
In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts
@ast
In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts
@en
In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts
@nl
type
label
In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts
@ast
In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts
@en
In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts
@nl
prefLabel
In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts
@ast
In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts
@en
In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts
@nl
P2093
P2860
P3181
P356
P1476
In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts
@en
P2093
P2860
P304
P3181
P356
10.1093/NAR/29.13.2766
P407
P577
2001-07-01T00:00:00Z